Millions will die if India stops AIDS drugs - U.N.

NEW DELHI Tue Jul 5, 2011 6:01pm IST

A sex worker holds a placard during an AIDS awareness rally to mark the World AIDS Day in Siliguri December 1, 2008. REUTERS/Rupak De Chowdhuri/Files

A sex worker holds a placard during an AIDS awareness rally to mark the World AIDS Day in Siliguri December 1, 2008.

Credit: Reuters/Rupak De Chowdhuri/Files

Related Topics

NEW DELHI (Reuters) - Millions of people dependent on life-saving generic drugs to treat HIV/AIDS will die if India stops producing cheap drugs for the disease due to its trade deal with the European Union, the head of UNAIDS warned on Tuesday.

The EU and India are currently negotiating a free-trade agreement, which campaigners say will restrict India's ability to produce anti-retroviral (ARV) drugs, preventing the world's poor from accessing cheap drugs for their treatment.

"India should resist removing any flexibility because any trade agreement which could lead to India not being able to produce will be terrible for the rest of the world," said Michel Sidibe, executive director for the Joint United Nations Programme on HIV/AIDS (UNAIDS).

"Millions of people will die if India cannot produce and Africa will be the most affected. For me, it is an issue of life or death," he told Reuters in an interview, adding that about 86 percent of people on treatment were taking drugs made in India.

The EU-India trade deal includes measures that could delay or restrict competition from generic medicines by extending patent terms, requiring data exclusivity and tightening border enforcement rules.

Such moves could drive up prices for India's anti-retroviral treatments, limit dosage options and delay access to newer and better drugs, said a U.N. report in September last year.

REVERSING GAINS MADE

Thirty years after the HIV/AIDS virus was first discovered, experts say while substantial progress has been made by the global community in stemming it, only a fraction of those living with the illness are on medication.

At a high level U.N. meeting last month, nations agreed on a set of ambitious targets to rid the world of disease, including scaling up the provision of generics to reach 15 million patients from six million by 2015.

The trade deal, Sidibe said, would reverse many of the gains made in improving the lives of the world's poor.

"We have been fighting for so long to make sure that poor people could have access to treatment," he said. "For me, it will be the beginning of reversing all the gains we made on social justice and redistribution of opportunity."

Sidibe, a Mali national, said African leaders were asking India to really pay serious attention to any trade agreement which would block them to produce quality generic drugs for very poor people.

"It is not a rich pocket of people in the developed world who will be deprived of drugs, it will be the most needy, the most poor."

(Editing by Yoko Nishikawa)

FILED UNDER:

SAARC Summit

REUTERS SHOWCASE

Rate Cut

Rate Cut

Markets pricing in rate cut, despite wary RBI.  Full Article 

Global Trade Deal

Global Trade Deal

WTO postpones trade deal by a day after last-minute objection.  Full Article 

Tax Dispute

Tax Dispute

India advised against challenging Vodafone tax ruling - source.  Full Article 

Racial Riots

Racial Riots

National Guard, police curb Ferguson unrest as protests swell across U.S.  Full Article 

Land Acquisitions

Land Acquisitions

Disputes over land for industry on the rise in India, angering locals - charities.  Full Article 

Scrubbing Results

Scrubbing Results

EU watchdogs to apply 'right to be forgotten' rule on Web worldwide.  Full Article 

Special Report

Special Report

Putin's allies channelled billions to Ukraine oligarch.  Full Article 

Flashback: 26/11 attacks

Flashback: 26/11 attacks

The three-day attack in November 2008 left 166 dead.  Slideshow 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage